FDA warning letter
Issue date
8 Jul 2020
Issuing office
Division of Pharmaceutical Quality Operations IV
Posted date
21 Jul 2020
Subject
CGMP/Finished Pharmaceuticals/Adulterated
Products & Services
Drugs
Stason Pharmaceuticals
Manufacturer
Warning letter
Headquarters
United States of AmericaSites
United States of America